Recombinant tissue plasminogen activator in two patients with basilar artery occlusion.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1901349.
- Also identified by PMC identifier 1014304.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two patients with angiographically proved basilar artery occlusion were treated with systemic recombinant tissue plasminogen activator (rtPA) according to protocol. The first patient was in a locked-in state and gradually deteriorated. On repeat angiography the basilar artery remained occluded. He died and necropsy revealed a pontine haemorrhagic infarction. The second patient, who was comatose and with decerebrate posturing, made a remarkable recovery. Angiography showed reperfusion. Therapy was initiated in the first patient after six hours and in the second after two hours. Treatment with rtPA is promising but probably not feasible for every patient. Success may depend on duration of occlusion and composition of occluding thrombus.
Medical subject headings
- Basilar Artery
- Brain Ischemia
- Brain Stem
- Intracranial Embolism and Thrombosis
- Tissue Plasminogen Activator
- Vertebrobasilar Insufficiency